AI takes on liver cancer: could a computer help pick the right immunotherapy?
NCT ID NCT07729618
First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time
Summary
This trial tests whether an artificial intelligence (AI) system can help doctors select the best first-line immune checkpoint inhibitor (ICI) therapy for adults with unresectable hepatocellular carcinoma (HCC), a type of advanced liver cancer. About 1,800 participants across 26 hospitals will be enrolled. Hospitals are randomly assigned to either use the AI tool or follow standard decision-making. The AI provides estimates and rankings of appropriate ICI options, but the final choice remains with the care team. The main goal is to see if AI-assisted selection improves progression-free survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- an artificial intelligence clinical decision-support system
- What this could lead to
- If it works, this could help doctors personalize immunotherapy choices for advanced liver cancer, potentially improving survival and quality of life.
- What could go wrong
- The AI is only advisory and may not outperform standard decision-making. The trial is large but pragmatic, so results may vary across hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an IDO1 inhibitor boost immunotherapy against liver cancer?
- Immunotherapy combo tested against untreatable liver cancer
- Liver cancer drug combo shows promise in large trial
- New hope for liver cancer patients with cirrhosis? tiny trial tests drug duo
- New radioactive beads aim to outperform standard liver cancer therapy
- New drug combo shows promise for untreatable liver tumors